The rise of Sildenafil initially drove a surge for the drug industry, but recent developments present a complicated outlook for investors. Off-patent versions are eroding profits, and persistent litigation add more https://mohamadpdof678033.diowebhost.com/96363911/viagra-and-pharma-a-volatile-play